AYUSH- 64: A potential therapeutic agent in COVID-19

Corona Virus disease (COVID-19) has become a global pandemic resulting in large scale morbidity and mortality worldwide. The management of COVID-19 has been a big challenge because of multifactorial pathophysiology and no specific treatment. AYUSH-64, a poly-herbal formulation developed by CCRAS, Mi...

Description complète

Détails bibliographiques
Auteurs principaux: Ashok Kumar Panda, Sarbeswar Kar, Amit Kumar Rai, B.C.S. Rao, N. Srikanth
Format: Article
Langue:English
Publié: Elsevier 2022-04-01
Collection:Journal of Ayurveda and Integrative Medicine
Sujets:
Accès en ligne:http://www.sciencedirect.com/science/article/pii/S0975947621002278